0.3266
price up icon0.00%   0.00
pre-market  Pre-mercato:  .33   0.0034   +1.04%
loading
Precedente Chiudi:
$0.3266
Aprire:
$0.326
Volume 24 ore:
213.32K
Relative Volume:
0.08
Capitalizzazione di mercato:
$29.37M
Reddito:
-
Utile/perdita netta:
$-166.14M
Rapporto P/E:
-0.1701
EPS:
-1.92
Flusso di cassa netto:
$-139.92M
1 W Prestazione:
+0.18%
1M Prestazione:
+35.97%
6M Prestazione:
-75.07%
1 anno Prestazione:
-67.66%
Intervallo 1D:
Value
$0.326
$0.3275
Intervallo di 1 settimana:
Value
$0.3211
$0.328
Portata 52W:
Value
$0.2157
$1.555

Allakos Inc Stock (ALLK) Company Profile

Name
Nome
Allakos Inc
Name
Telefono
650-597-5002
Name
Indirizzo
825 INDUSTRIAL ROAD, SAN CARLOS, CA
Name
Dipendente
61
Name
Cinguettio
Name
Prossima data di guadagno
2025-03-12
Name
Ultimi documenti SEC
Name
ALLK's Discussions on Twitter

Confronta ALLK con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
ALLK
Allakos Inc
0.3266 29.37M 0 -166.14M -139.92M -1.92
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
493.84 122.76B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
602.64 61.38B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
614.76 36.37B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
251.56 30.12B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
244.90 24.70B 3.81B -644.79M -669.77M -6.24

Allakos Inc Stock (ALLK) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-01-17 Downgrade Jefferies Buy → Hold
2024-01-16 Downgrade Cantor Fitzgerald Overweight → Neutral
2023-12-18 Aggiornamento William Blair Mkt Perform → Outperform
2023-12-08 Ripresa Jefferies Buy
2023-09-27 Iniziato JMP Securities Mkt Outperform
2023-05-12 Aggiornamento Jefferies Hold → Buy
2023-03-07 Iniziato Piper Sandler Overweight
2022-09-12 Downgrade SMBC Nikko Neutral → Underperform
2021-12-22 Downgrade BofA Securities Buy → Underperform
2021-12-22 Downgrade Cowen Outperform → Market Perform
2021-12-22 Downgrade Jefferies Buy → Hold
2021-12-22 Downgrade SVB Leerink Outperform → Mkt Perform
2021-12-22 Downgrade William Blair Outperform → Mkt Perform
2021-08-26 Iniziato Morgan Stanley Equal-Weight
2021-07-15 Iniziato Cowen Outperform
2021-05-18 Iniziato H.C. Wainwright Buy
2021-02-24 Iniziato Cantor Fitzgerald Overweight
2021-01-15 Iniziato BofA Securities Buy
2020-12-21 Iniziato SVB Leerink Outperform
2020-02-27 Iniziato Barclays Underweight
2020-02-04 Ripresa Goldman Neutral
2018-08-13 Iniziato Goldman Neutral
2018-08-13 Iniziato Jefferies Buy
2018-08-13 Iniziato William Blair Outperform
Mostra tutto

Allakos Inc Borsa (ALLK) Ultime notizie

pulisher
Apr 27, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 27, 2025
pulisher
Apr 22, 2025

Checking in on Allakos Inc (ALLK) after recent insiders movement - knoxdaily.com

Apr 22, 2025
pulisher
Apr 04, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates COOP, HMST, ALLK, OPOF on Behalf of Shareholders - PR Newswire

Apr 04, 2025
pulisher
Apr 03, 2025

Allakos Inc (ALLK) Recovers 48.96% From Low: Are We There Yet? - stocksregister.com

Apr 03, 2025
pulisher
Apr 03, 2025

Allakos And 2 Other Promising Penny Stocks To Watch - simplywall.st

Apr 03, 2025
pulisher
Apr 03, 2025

Short Interest in Allakos Inc. (NASDAQ:ALLK) Decreases By 13.9% - Defense World

Apr 03, 2025
pulisher
Apr 02, 2025

$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Allakos Inc.ALLK - PR Newswire

Apr 02, 2025
pulisher
Apr 02, 2025

Concentra Biosciences, LLC entered into an agreement to acquire Allakos Inc. for $31 million. - marketscreener.com

Apr 02, 2025
pulisher
Apr 02, 2025

Allakos Inc Inc. (ALLK) Price Performance: A Technical Analysis Perspective - investchronicle.com

Apr 02, 2025
pulisher
Apr 02, 2025

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Allakos, Inc. (ALLK) - TradingView

Apr 02, 2025
pulisher
Apr 02, 2025

12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga

Apr 02, 2025
pulisher
Apr 02, 2025

Tang Capital’s Concentra nabs a win, making a deal to buy Allakos - Endpoints News

Apr 02, 2025
pulisher
Apr 02, 2025

Allakos to be acquired by Concentra Biosciences for 33c per share in cash - TipRanks

Apr 02, 2025
pulisher
Apr 02, 2025

ALLK Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Allakos Inc. Is Fair to Shareholders - The Joplin Globe

Apr 02, 2025
pulisher
Apr 02, 2025

Allakos to Be Acquired by Concentra Biosciences for $0.33 per Share - MarketScreener

Apr 02, 2025
pulisher
Apr 02, 2025

Allakos Announces Merger Agreement with Concentra Biosciences - TipRanks

Apr 02, 2025
pulisher
Apr 02, 2025

Shareholder Alert: The Ademi Firm Investigates Whether Allakos Inc. Is Obtaining a Fair Price for Its Public Shareholders - Bluefield Daily Telegraph

Apr 02, 2025
pulisher
Apr 02, 2025

Allakos agrees to Concentra Biosciences acquisition - Investing.com

Apr 02, 2025
pulisher
Apr 02, 2025

Allakos surges on reverse merger deal with Concentra Biosciences - Seeking Alpha

Apr 02, 2025
pulisher
Apr 02, 2025

Allakos to Be Acquired for 33 Cents a Share - MarketWatch

Apr 02, 2025
pulisher
Apr 02, 2025

Allakos Inc. Enters into Agreement to Be Acquired by Concentra Biosciences, LLC for $0.33 in Cash per Share - The Manila Times

Apr 02, 2025
pulisher
Apr 02, 2025

Allakos Inc. Enters Into Agreement To Be Acquired By Concentra Biosciences - MarketScreener

Apr 02, 2025
pulisher
Apr 02, 2025

Allakos (ALLK) Enters into Agreement to Be Acquired by Concentra Biosciences, LLC for $0.33 in Cash per Share - StreetInsider

Apr 02, 2025
pulisher
Apr 02, 2025

Allakos Inc. Enters into Agreement to Be Acquired by Concentra Biosciences, LLC for $0.33 in - Bluefield Daily Telegraph

Apr 02, 2025
pulisher
Apr 02, 2025

Biotech Deal Alert: Concentra Biosciences Acquires AllakosKey Terms Revealed - Stock Titan

Apr 02, 2025
pulisher
Apr 01, 2025

ALLK ALERT: ROSEN, A LEADING FIRM, Reminds Allakos Inc. Investors of Important May 11th Deadline in Securities Class Action First Filed By Firm- ALLK - ACCESS Newswire

Apr 01, 2025
pulisher
Mar 26, 2025

Allakos stock plunges to 52-week low of $0.23 amid market challenges By Investing.com - Investing.com South Africa

Mar 26, 2025
pulisher
Mar 26, 2025

Allakos stock plunges to 52-week low of $0.23 amid market challenges - Investing.com Australia

Mar 26, 2025
pulisher
Mar 24, 2025

Shareholder Alert: The Ademi Firm Investigates Whether LENSAR, Inc. is Obtaining a Fair Price for Its Public Shareholders - Business Wire

Mar 24, 2025
pulisher
Mar 20, 2025

Shareholder Alert: The Ademi Firm investigates whether Optinose, Inc. is obtaining a Fair Price for its Public Shareholders - Business Wire

Mar 20, 2025
pulisher
Mar 20, 2025

Allakos Inc. (NASDAQ:ALLK) Short Interest Update - Defense World

Mar 20, 2025
pulisher
Mar 18, 2025

Analyzing Allakos (NASDAQ:ALLK) and Acerus Pharmaceuticals (OTCMKTS:TRLPF) - Defense World

Mar 18, 2025
pulisher
Mar 17, 2025

Allakos Inc.: Hold Rating Amid Restructuring and Financial Uncertainty - TipRanks

Mar 17, 2025
pulisher
Mar 14, 2025

Allakos faces potential Nasdaq delisting over share price By Investing.com - Investing.com India

Mar 14, 2025
pulisher
Mar 14, 2025

Allakos Reports Q4 2024 Results Amid Strategic Shift - TipRanks

Mar 14, 2025
pulisher
Mar 13, 2025

Allakos faces potential Nasdaq delisting over share price - Investing.com

Mar 13, 2025
pulisher
Mar 12, 2025

Allakos Inc. (ALLK) reports earnings - Quartz

Mar 12, 2025
pulisher
Mar 12, 2025

Allakos Provides Business Update and Reports Fourth Quarter 2024 Financial Results - The Manila Times

Mar 12, 2025
pulisher
Mar 12, 2025

Allakos Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 12, 2025
pulisher
Mar 12, 2025

Allakos Swings to Surprise Q4 Profit as Major Restructuring Takes Shape - StockTitan

Mar 12, 2025
pulisher
Mar 10, 2025

Shareholder Alert: The Ademi Firm Investigates Whether Checkpoint Therapeutics, Inc. is Obtaining a Fair Price for Its Public Shareholders - Business Wire

Mar 10, 2025
pulisher
Mar 06, 2025

Allakos (ALLK) Projected to Post Quarterly Earnings on Thursday - Defense World

Mar 06, 2025
pulisher
Mar 01, 2025

The Curious Case of Allakos - substack.com

Mar 01, 2025
pulisher
Feb 26, 2025

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Urges Allakos (ALLK) Investors with Losses to Contact Its Attorneys: 3 DAY APPLICATION DEADLINE ALERT - ACCESS Newswire

Feb 26, 2025
pulisher
Feb 22, 2025

Allakos Inc. (ALLK) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - ACCESS Newswire

Feb 22, 2025
pulisher
Feb 12, 2025

Lee joins Lycia as CMO - BioCentury

Feb 12, 2025
pulisher
Feb 11, 2025

It is Poised to be a Bull Market for Allakos Inc (ALLK) - SETE News

Feb 11, 2025
pulisher
Feb 10, 2025

Kuehn Law Encourages Investors of Allakos Inc. to Contact Law Firm - EIN News

Feb 10, 2025
pulisher
Feb 10, 2025

Introducing Our Rant Against Allakos Inc - US Post News

Feb 10, 2025
pulisher
Feb 08, 2025

FY2024 EPS Estimates for Allakos Lowered by Leerink Partnrs - Defense World

Feb 08, 2025
pulisher
Feb 07, 2025

Allakos Inc [ALLK] Officer makes an insider purchase of 21,116 shares worth 23219.0. - Knox Daily

Feb 07, 2025

Allakos Inc Azioni (ALLK) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$20.59
price up icon 0.24%
$69.69
price up icon 1.06%
$32.20
price up icon 0.53%
$23.46
price down icon 36.06%
$102.02
price down icon 15.36%
biotechnology ONC
$244.90
price down icon 4.40%
Capitalizzazione:     |  Volume (24 ore):